This post outlines practical steps Congress should take to strengthen pharmaceutical border security, reinforce regulatory oversight, and protect patients.
A patient at a North Dakota med spa told investigators she had to coach the clinic owner through the IV administration process. The owner allegedly presented herself as a registered nurse, despite holding no medical licenses.
The bill will protect Iowa’s patients by closing enormous regulatory gaps in the med spa and wellness industry.
The agency has found websites and social media advertisements displaying official Health Canada logos with fake endorsements to mislead consumers, and said that it doesn’t endorse health products or permit its logo to be used in ads that promote them.
Reporting on PSM-led research led Google to suppress pill press ads, Congressman Raja Krishnamoorthi sent letters to shippers of weight loss drugs and API, and a former nurse was charged with distributing counterfeit Ozempic.
As of the first week of January, we found several companies with multiple ads still running well past its self-imposed deadline. Google can do better, but will they?
The FDA has posted notices for two nationwide dietary supplement recalls involving products found to contain undeclared pharmaceutical ingredients.
Our podcast covers the latest in pharma crime and medicine safety.
Like your information on video? Subscribe to our YouTube playlist!
A recent FDA warning letter highlights upstream supply chain vulnerabilities.
Troubling practices alleged at a compounding pharmacy that supplied glp-1s. Learn more.
Congressman Krishnamoorthy is looking into GLP-1 drugs that may be entering the US unlawfully.
Click the images below to see more recent videos.